Gapping up
Other news:
- RYZB +97.1% (to be acquired by Bristol-Myers (BMY) for $62.50/share
- GRCL +58.0% (to be acquired by AstraZeneca (AZN), furthering cell therapy ambition across oncology and autoimmune diseases for $10.00/ADS)
- SSYS +10.5% (Nano Dimension (NNDM) announces preliminary all cash proposal to acquire Stratasys (SSYS) for $16.50/share)
- HOLI +5.8% (Buyer consortium led by Dazheng Group announces enhanced all-cash proposal of $29.00/share to acquire HOLI)
- MANU +4.7% (reaches agreement for Sir Jim Ratcliffe, Chairman of INEOS, to acquire up to a 25% shareholding in the company)
- NIO +3.0% (confirms in filing that it launched the ET9, a smart electric executive flagship)
- NTES +2.7% (China aiming to soften stance on gaming, according to Bloomberg)
- LIAN +2.4% (enters into agreement assigning its rights for NBTXR3 in China and other Asian markets)
- ANSS +2.0% ( Synopsys (SNPS) has submitted an offer to acquire ANSS, citing people familiar; offers received value ANSS at well over $400/sh, according to Reuters)
- INTC +1.9% (Israel grants INTC $3.2 bln for new $25 bln chip plant, according to Reuters)
- GMRE +1.2% (files mixed securities shelf offering)
- SNPS +1.2% (has submitted an offer to acquire ANSS, citing people familiar; offers received value ANSS at well over $400/sh, according to Reuters)
Analyst comments:
- TYRA +2.5% (reiterated with Buy rating at H.C. Wainwright)